Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy

Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy: A Randomized Controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03298646

Enrollment

Registered

2017-10-02

Start date

2017-10-31

Completion date

2018-01-31

Last updated

2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nulliparity

Brief summary

Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy. A Randomized Controlled Trial.

Detailed description

10 ml of 2% lidocaine hydrochloride added on saline infusion media versus 100 mg diclofenac tablet 1 hour before office hysteroscopy , to test their efficacy in reducing pain .

Interventions

DRUGLidocaine Hydrochloride

10 ml of 2% lidocaine on hysteroscopic infusion media during office hysteroscopy.

DRUGDiclofenac

100 mg Diclofenac oral tablet one hour before the procedure.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Caregiver)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* Age: 18-35 years. * BMI 18.5-30 Kg. * Nulliparous women assigned for diagnostic hysteroscopy. * Informed written consent.

Exclusion criteria

* Previous cervical surgery. * Cervical stenosis. * Known gastritis. * Recent or active PID. * Cardiac patients.

Design outcomes

Primary

Measure	Time frame	Description
Pain reduction using Visual Analogue Scale	30 minutes	Efficacy of lidocaine on saline media and oral diclofenac in reducing pain during office hysteroscopy from start of the procedure till 30 minutes after, using visual analogue scale to assess the severity of pain

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026